Market Lens IQ is a global market intelligence and strategic consulting firm delivering advanced syndicated research reports, customized industry analysis, competitive intelligence, and data-driven advisory solutions to organizations across international markets. With a strong commitment to analytical excellence and innovation, Market Lens IQ empowers enterprises, investors, consultants, and decision-makers with actionable insights that drive strategic growth, operational efficiency, and long-term business transformation in highly competitive industries. The company serves a broad spectrum of industry verticals, including Life Sciences, Consumer Goods, Semiconductor and Electronics, Materials and Chemicals, Construction and Manufacturing, Food and Beverages, Energy and Power, Automotive and Transportation, ICT and Media, Aerospace and Defense, and BFSI (Banking, Financial Services, and Insurance). By combining deep domain expertise with advanced analytics, Market Lens IQ delivers comprehensive market assessments, technology trend analysis, investment intelligence, supply chain insights, pricing analysis, customer behavior studies, and future market forecasts tailored to evolving business requirements.
At the core of Market Lens IQ’s capabilities lies a robust 360-degree research methodology integrating primary research, secondary research, expert interviews, data triangulation, AI- powered analytics, and real-time market monitoring. Our research framework ensures the highest standards of data accuracy, reliability, and strategic relevance by leveraging industry databases, corporate filings, government publications, trade journals, regulatory frameworks, white papers, investor presentations, and global economic indicators. The company specializes in identifying emerging market opportunities, disruptive technologies, innovation ecosystems, competitive benchmarking, regulatory shifts, and high-growth investment segments across global industries. Driven by a client-centric approach, Market Lens IQ collaborates with startups, SMEs, multinational enterprises, private equity firms, institutional investors, and Fortune 500 companies to deliver high-value business intelligence solutions that support informed decision-making and sustainable competitive advantage. Through continuous innovation, digital intelligence capabilities, and industry-focused expertise, Market Lens IQ has established itself as a trusted strategic partner in the global market research and consulting landscape, helping organizations navigate market complexities and capitalize on transformative growth opportunities.
In-depth Analysis Tailored to Specified Regions or Segments
Company Profiles Customized to User Preferences
Comprehensive Insights Focused on Specific Segments or Regions
Embolization Particle Market by Type: Size, CAGR & Forecast
Embolization Particle Market by Type
Embolization Particle Market by Type: Size, CAGR & Forecast
Embolization Particle Market by Type by Product Type (Radioembolization, Drug-Eluting Beads), by Structure (Calibrated Spherical Microspheres, Non-Spherical/Irregular Particles), by Function (Plain/Non-Drug-Eluting Embolics, Drug-Eluting Embolics), by Material (PVA-Based, Tris-Acryl Gelatin Microspheres, Ceramic, Bioresorbable), by Particle Size (100-300 µm, <100 µm, 300-500 µm, >500 µm), by Delivery Format (Vial-Based, Pre-Loaded Syringe), by Application (Oncology, Peripheral Vascular Disease, Neurology, Uterine Fibroids, Hemorrhage), by End Use (Hospitals & Clinics, Ambulatory Surgical Centers), by North America (USA, Canada, Mexico), by Europe (Germany, UK, France, Italy, Spain), by Asia Pacific (China, Japan, India, South Korea, Australia), by Latin America (Brazil, Argentina), by Middle East & Africa (UAE, Saudi Arabia, South Africa) Forecast 2026-2034
Updated On : Nov 8, 2026|Base Year : 2025|Pages : 260
Embolization Particle Market by Type: Valuation and Type Segmentation
The global embolization particle market entered a high-growth phase in 2025, valued at approximately USD 1.34 billion and projected to reach USD 3.79 billion by 2034 at a 12.27% CAGR. Embolization particles are micron-scale occlusive agents delivered via microcatheter to selectively block tumor-feeding and abnormal vessels in interventional radiology.
Embolization Particle by Type Market Size (In Billion)
3.0B
2.0B
1.0B
0
1.340 B
2025
1.504 B
2026
1.689 B
2027
1.896 B
2028
2.129 B
2029
2.390 B
2030
2.683 B
2031
Embolization Particle by Type Market Size (In Billion)
Year
Market Size
2025
1.340 B
2026
1.504 B
2027
1.689 B
2028
1.896 B
2029
2.129 B
2030
2.390 B
2031
2.683 B
The type taxonomy is the single most consequential segmentation axis in this market, because particle architecture dictates occlusion durability, imaging visibility, and drug-carrying capacity. Our proprietary segmentation is summarized below.
Type Classification Basis
Leading Sub-Segment (2025)
Fastest-Growing Sub-Segment
Function
Radioembolization particles
Drug-eluting beads
Structure
Calibrated spherical microspheres
Non-spherical/irregular particles
Material
PVA-based materials
Bioresorbable and ceramic microspheres
Particle size
100-300 µm band
<100 µm precision bands
Delivery format
Vial-based dry particles
Pre-loaded syringe systems
Radioembolization carriers hold the largest type share, anchored by yttrium-90 glass and resin microspheres for hepatic malignancies.
Drug-eluting beads display the steepest trajectory, converting transcatheter arterial chemoembolization from bolus delivery to sustained local chemotherapy.
Calibrated spherical microspheres command the majority of structural share due to predictable vascular occlusion and lower catheter clogging risk.
Radioembolization Microspheres and Liver Cancer Load
Radioembolization remains the revenue anchor of the type mix. Its dominance is structurally tied to hepatocellular carcinoma and metastatic colorectal liver disease volumes, where beta-emitting microspheres deliver internal radiation directly to hypervascular tumor beds while sparing parenchyma.
Demand intensity is supported by rising liver cancer incidence tracked by the International Agency for Cancer Research, with patients unsuitable for resection representing the core addressable population.
Repeat and sequential embolization protocols generate recurring particle consumption per patient, lifting per-capita revenue.
Logistics complexity (dosimetry, radiation handling, specialized supply chains) creates high barriers and premium pricing.
Drug-Eluting Beads and Chemoembolization Convergence
The drug-eluting bead type is the fastest-growing segment across our forward model. These ion-exchange microspheres load doxorubicin or irinotecan and release chemotherapy over days to weeks at the tumor site.
Attribute
Plain Embolic Particles
Drug-Eluting Beads
Mechanism
Mechanical occlusion only
Occlusion plus sustained local chemotherapy
Systemic toxicity
Low
Lower than systemic IV dosing
Repeatability
High
Moderate, protocol-dependent
Pricing premium
Baseline
Substantially higher per vial
Growth is reinforced by clinical preference for targeted, reduced-toxicity locoregional therapy in intermediate-stage liver cancer.
Adjacent expansions into colorectal liver metastases and, investigatively, breast and lung tumors broaden the addressable base beyond hepatology.
Material Innovation in PVA, Gelatin and Ceramic Microspheres
Material chemistry is the decisive differentiator across the type landscape. Polyvinyl alcohol (PVA) particles and tris-acryl gelatin microspheres (TAGM) remain the workhorse platforms for hemorrhage control, uterine fibroids, and hypervascular tumor devascularization.
PVA-based materials lead total material share given their compressibility, irregular occlusion profiles, and broad caliber matching.
Tris-acryl gelatin microspheres offer calibrated, hydrophilic, compressible behavior favored in uterine artery and prostate artery embolization.
Ceramic microsphere development, including joint-development activity between advanced ceramics specialists and oncology embolization technology firms in late 2024, signals a new radio-opaque and bio-inert material frontier.
Bioresorbable and biocompatible material programs target reduced long-term complication profiles, particularly in benign indications.
Application Verticals: Oncology, Peripheral Vascular and Uterine Fibroids
Oncology accounts for the largest application share of particle demand in 2025, spanning transcatheter arterial chemoembolization, radioembolization, and pre-surgical devascularization. Peripheral vascular disease is the fastest-growing application, propelled by hemorrhage control, arteriovenous malformations, and aneurysm-adjacent occlusion.
Uterine fibroids: uterine artery embolization offers uterus-preserving, minimally invasive therapy for a condition affecting up to 70% of women by menopause (per FIGO data).
Hemorrhage and trauma: emergency embolization caseloads are rising alongside aging populations and anticoagulant use.
Neurology: particle use in selected neurovascular occlusion remains a smaller but technically demanding niche.
Prostate artery embolization for benign prostatic hyperplasia is an emerging volume driver for calibrated spherical types.
Supply Dynamics, Hospital Procurement and Trade Flows
Particle supply chains are concentrated around medical-grade polymer and gelatin microsphere manufacturing, gamma-sterilization capacity, and specialized packaging. Trade flows are modest relative to device categories because particles are low-mass, high-value, and frequently shipped as sterilized finished goods under cold-chain or radiation-logistics protocols.
Hospitals and clinics dominate end-user consumption, reflecting dedicated interventional radiology suites, 24/7 catheterization lab support, and multidisciplinary backup.
Ambulatory surgical centers are gaining share for elective uterine fibroid and peripheral procedures.
Cost of procedure kits, imaging support, and embolic agents remains the principal access restraint in emerging markets with limited reimbursement.
AI-Assisted Dosimetry and Patient-Specific Particle Selection
AI is becoming embedded in type selection rather than as a standalone product. Algorithms support image analysis, tumor-feeding vessel mapping, response prediction, and customized particle size and shape planning.
Personalized embolization planning favors calibrated, narrow-size-band and drug-eluting formats with predictable behavior.
Imaging integration improves microcatheter navigation confidence, expanding particle use in complex anatomy.
Regulatory streamlining for novel embolic materials in major markets is shortening time-to-adoption.
Competitive Consolidation and Regional Revenue Concentration
North America leads regional revenue, supported by dense interventional radiology infrastructure and oncology trial activity. Asia Pacific is the fastest-growing region, driven by expanding cancer burden, novel technology adoption, and interventional radiology capacity build-out.
Embolization Particle Market by Type Regional Market Share
Loading chart...
Embolization Particle Market by Type Regional Market Share
Region
Market Share (%)
North America
0.34%
Europe
0.24%
Asia-Pacific
0.28%
South America
0.07%
Middle East & Africa
0.07%
Strategic consolidation is reshaping portfolios, headlined by large-scale embolization and thrombectomy acquisitions announced in 2025 and early 2026.
Europe grows through minimally invasive treatment adoption and structured reimbursement pathways.
Latin America and the Middle East & Africa are early-stage but expanding via advanced embolization technology introduction.
Embolization Particle Market by Type Regional Market Share
Higher Coverage
Lower Coverage
No Coverage
Embolization Particle Market by Type REPORT HIGHLIGHTS
Aspects
Details
Study Period
2020-2034
Base Year
2025
Estimated Year
2026
Forecast Period
2026-2034
Historical Period
2020-2025
Growth Rate
CAGR of 12.27% from 2020-2034
Segmentation
By Product Type
Radioembolization
Drug-Eluting Beads
By Structure
Calibrated Spherical Microspheres
Non-Spherical/Irregular Particles
By Function
Plain/Non-Drug-Eluting Embolics
Drug-Eluting Embolics
By Material
PVA-Based
Tris-Acryl Gelatin Microspheres
Ceramic
Bioresorbable
By Particle Size
100-300 µm
<100 µm
300-500 µm
>500 µm
By Delivery Format
Vial-Based
Pre-Loaded Syringe
By Application
Oncology
Peripheral Vascular Disease
Neurology
Uterine Fibroids
Hemorrhage
By End Use
Hospitals & Clinics
Ambulatory Surgical Centers
By Geography
North America
USA
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Asia Pacific
China
Japan
India
South Korea
Australia
Latin America
Brazil
Argentina
Middle East & Africa
UAE
Saudi Arabia
South Africa
Table of Contents
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Objective
1.4. Definitions and Assumptions
2. Executive Summary
2.1. Market Snapshot
3. Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Trends
3.4. Market Opportunity
4. Market Factor Analysis
4.1. Porters Five Forces
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. PESTEL analysis
4.3. BCG Analysis
4.3.1. Stars (High Growth, High Market Share)
4.3.2. Cash Cows (Low Growth, High Market Share)
4.3.3. Question Mark (High Growth, Low Market Share)
4.3.4. Dogs (Low Growth, Low Market Share)
4.4. Ansoff Matrix Analysis
4.5. Supply Chain Analysis
4.6. Regulatory Landscape
4.7. Current Market Potential and Opportunity Assessment (TAM–SAM–SOM Framework)
4.8. MIQ Analyst Note
5. Market Analysis, Insights and Forecast, 2020-2034
5.1. Market Analysis, Insights and Forecast - by Product Type
5.1.1. Radioembolization
5.1.2. Drug-Eluting Beads
5.2. Market Analysis, Insights and Forecast - by Structure
5.2.1. Calibrated Spherical Microspheres
5.2.2. Non-Spherical/Irregular Particles
5.3. Market Analysis, Insights and Forecast - by Function
5.3.1. Plain/Non-Drug-Eluting Embolics
5.3.2. Drug-Eluting Embolics
5.4. Market Analysis, Insights and Forecast - by Material
5.4.1. PVA-Based
5.4.2. Tris-Acryl Gelatin Microspheres
5.4.3. Ceramic
5.4.4. Bioresorbable
5.5. Market Analysis, Insights and Forecast - by Particle Size
5.5.1. 100-300 µm
5.5.2. <100 µm
5.5.3. 300-500 µm
5.5.4. >500 µm
5.6. Market Analysis, Insights and Forecast - by Delivery Format
5.6.1. Vial-Based
5.6.2. Pre-Loaded Syringe
5.7. Market Analysis, Insights and Forecast - by Application
5.7.1. Oncology
5.7.2. Peripheral Vascular Disease
5.7.3. Neurology
5.7.4. Uterine Fibroids
5.7.5. Hemorrhage
5.8. Market Analysis, Insights and Forecast - by End Use
5.8.1. Hospitals & Clinics
5.8.2. Ambulatory Surgical Centers
5.9. Market Analysis, Insights and Forecast - by Region
5.9.1. North America
5.9.2. Europe
5.9.3. Asia Pacific
5.9.4. Latin America
5.9.5. Middle East & Africa
6. North America Market Analysis, Insights and Forecast, 2020-2034
6.1. Market Analysis, Insights and Forecast - by Product Type
6.1.1. Radioembolization
6.1.2. Drug-Eluting Beads
6.2. Market Analysis, Insights and Forecast - by Structure
6.2.1. Calibrated Spherical Microspheres
6.2.2. Non-Spherical/Irregular Particles
6.3. Market Analysis, Insights and Forecast - by Function
6.3.1. Plain/Non-Drug-Eluting Embolics
6.3.2. Drug-Eluting Embolics
6.4. Market Analysis, Insights and Forecast - by Material
6.4.1. PVA-Based
6.4.2. Tris-Acryl Gelatin Microspheres
6.4.3. Ceramic
6.4.4. Bioresorbable
6.5. Market Analysis, Insights and Forecast - by Particle Size
6.5.1. 100-300 µm
6.5.2. <100 µm
6.5.3. 300-500 µm
6.5.4. >500 µm
6.6. Market Analysis, Insights and Forecast - by Delivery Format
6.6.1. Vial-Based
6.6.2. Pre-Loaded Syringe
6.7. Market Analysis, Insights and Forecast - by Application
6.7.1. Oncology
6.7.2. Peripheral Vascular Disease
6.7.3. Neurology
6.7.4. Uterine Fibroids
6.7.5. Hemorrhage
6.8. Market Analysis, Insights and Forecast - by End Use
6.8.1. Hospitals & Clinics
6.8.2. Ambulatory Surgical Centers
7. Europe Market Analysis, Insights and Forecast, 2020-2034
7.1. Market Analysis, Insights and Forecast - by Product Type
7.1.1. Radioembolization
7.1.2. Drug-Eluting Beads
7.2. Market Analysis, Insights and Forecast - by Structure
7.2.1. Calibrated Spherical Microspheres
7.2.2. Non-Spherical/Irregular Particles
7.3. Market Analysis, Insights and Forecast - by Function
7.3.1. Plain/Non-Drug-Eluting Embolics
7.3.2. Drug-Eluting Embolics
7.4. Market Analysis, Insights and Forecast - by Material
7.4.1. PVA-Based
7.4.2. Tris-Acryl Gelatin Microspheres
7.4.3. Ceramic
7.4.4. Bioresorbable
7.5. Market Analysis, Insights and Forecast - by Particle Size
7.5.1. 100-300 µm
7.5.2. <100 µm
7.5.3. 300-500 µm
7.5.4. >500 µm
7.6. Market Analysis, Insights and Forecast - by Delivery Format
7.6.1. Vial-Based
7.6.2. Pre-Loaded Syringe
7.7. Market Analysis, Insights and Forecast - by Application
7.7.1. Oncology
7.7.2. Peripheral Vascular Disease
7.7.3. Neurology
7.7.4. Uterine Fibroids
7.7.5. Hemorrhage
7.8. Market Analysis, Insights and Forecast - by End Use
7.8.1. Hospitals & Clinics
7.8.2. Ambulatory Surgical Centers
8. Asia Pacific Market Analysis, Insights and Forecast, 2020-2034
8.1. Market Analysis, Insights and Forecast - by Product Type
8.1.1. Radioembolization
8.1.2. Drug-Eluting Beads
8.2. Market Analysis, Insights and Forecast - by Structure
8.2.1. Calibrated Spherical Microspheres
8.2.2. Non-Spherical/Irregular Particles
8.3. Market Analysis, Insights and Forecast - by Function
8.3.1. Plain/Non-Drug-Eluting Embolics
8.3.2. Drug-Eluting Embolics
8.4. Market Analysis, Insights and Forecast - by Material
8.4.1. PVA-Based
8.4.2. Tris-Acryl Gelatin Microspheres
8.4.3. Ceramic
8.4.4. Bioresorbable
8.5. Market Analysis, Insights and Forecast - by Particle Size
8.5.1. 100-300 µm
8.5.2. <100 µm
8.5.3. 300-500 µm
8.5.4. >500 µm
8.6. Market Analysis, Insights and Forecast - by Delivery Format
8.6.1. Vial-Based
8.6.2. Pre-Loaded Syringe
8.7. Market Analysis, Insights and Forecast - by Application
8.7.1. Oncology
8.7.2. Peripheral Vascular Disease
8.7.3. Neurology
8.7.4. Uterine Fibroids
8.7.5. Hemorrhage
8.8. Market Analysis, Insights and Forecast - by End Use
8.8.1. Hospitals & Clinics
8.8.2. Ambulatory Surgical Centers
9. Latin America Market Analysis, Insights and Forecast, 2020-2034
9.1. Market Analysis, Insights and Forecast - by Product Type
9.1.1. Radioembolization
9.1.2. Drug-Eluting Beads
9.2. Market Analysis, Insights and Forecast - by Structure
9.2.1. Calibrated Spherical Microspheres
9.2.2. Non-Spherical/Irregular Particles
9.3. Market Analysis, Insights and Forecast - by Function
9.3.1. Plain/Non-Drug-Eluting Embolics
9.3.2. Drug-Eluting Embolics
9.4. Market Analysis, Insights and Forecast - by Material
9.4.1. PVA-Based
9.4.2. Tris-Acryl Gelatin Microspheres
9.4.3. Ceramic
9.4.4. Bioresorbable
9.5. Market Analysis, Insights and Forecast - by Particle Size
9.5.1. 100-300 µm
9.5.2. <100 µm
9.5.3. 300-500 µm
9.5.4. >500 µm
9.6. Market Analysis, Insights and Forecast - by Delivery Format
9.6.1. Vial-Based
9.6.2. Pre-Loaded Syringe
9.7. Market Analysis, Insights and Forecast - by Application
9.7.1. Oncology
9.7.2. Peripheral Vascular Disease
9.7.3. Neurology
9.7.4. Uterine Fibroids
9.7.5. Hemorrhage
9.8. Market Analysis, Insights and Forecast - by End Use
9.8.1. Hospitals & Clinics
9.8.2. Ambulatory Surgical Centers
10. Middle East & Africa Market Analysis, Insights and Forecast, 2020-2034
10.1. Market Analysis, Insights and Forecast - by Product Type
10.1.1. Radioembolization
10.1.2. Drug-Eluting Beads
10.2. Market Analysis, Insights and Forecast - by Structure
10.2.1. Calibrated Spherical Microspheres
10.2.2. Non-Spherical/Irregular Particles
10.3. Market Analysis, Insights and Forecast - by Function
10.3.1. Plain/Non-Drug-Eluting Embolics
10.3.2. Drug-Eluting Embolics
10.4. Market Analysis, Insights and Forecast - by Material
10.4.1. PVA-Based
10.4.2. Tris-Acryl Gelatin Microspheres
10.4.3. Ceramic
10.4.4. Bioresorbable
10.5. Market Analysis, Insights and Forecast - by Particle Size
10.5.1. 100-300 µm
10.5.2. <100 µm
10.5.3. 300-500 µm
10.5.4. >500 µm
10.6. Market Analysis, Insights and Forecast - by Delivery Format
10.6.1. Vial-Based
10.6.2. Pre-Loaded Syringe
10.7. Market Analysis, Insights and Forecast - by Application
10.7.1. Oncology
10.7.2. Peripheral Vascular Disease
10.7.3. Neurology
10.7.4. Uterine Fibroids
10.7.5. Hemorrhage
10.8. Market Analysis, Insights and Forecast - by End Use
10.8.1. Hospitals & Clinics
10.8.2. Ambulatory Surgical Centers
11. Competitive Analysis
11.1. Company Profiles
11.1.1. Boston Scientific Corporation
11.1.1.1. Company Overview
11.1.1.2. Products
11.1.1.3. Company Financials
11.1.1.4. SWOT Analysis
11.1.2. Cook Medical
11.1.2.1. Company Overview
11.1.2.2. Products
11.1.2.3. Company Financials
11.1.2.4. SWOT Analysis
11.1.3. Merit Medical Systems
11.1.3.1. Company Overview
11.1.3.2. Products
11.1.3.3. Company Financials
11.1.3.4. SWOT Analysis
11.1.4. Sirtex Medical
11.1.4.1. Company Overview
11.1.4.2. Products
11.1.4.3. Company Financials
11.1.4.4. SWOT Analysis
11.1.5. BTG plc
11.1.5.1. Company Overview
11.1.5.2. Products
11.1.5.3. Company Financials
11.1.5.4. SWOT Analysis
11.1.6. Terumo Corporation
11.1.6.1. Company Overview
11.1.6.2. Products
11.1.6.3. Company Financials
11.1.6.4. SWOT Analysis
11.1.7. Guerbet
11.1.7.1. Company Overview
11.1.7.2. Products
11.1.7.3. Company Financials
11.1.7.4. SWOT Analysis
11.1.8. Medtronic
11.1.8.1. Company Overview
11.1.8.2. Products
11.1.8.3. Company Financials
11.1.8.4. SWOT Analysis
11.1.9. Varian Medical Systems Inc.
11.1.9.1. Company Overview
12. Research Methodology
List of Figures
Figure 1: Embolization Particle Market by Type Revenue Breakdown (Billion, %) by Region 2026 & 2034
Figure 2: North America Embolization Particle Market by Type Revenue (Billion), by Product Type 2026 & 2034
Figure 3: North America Embolization Particle Market by Type Revenue Share (%), by Product Type 2026 & 2034
Figure 4: North America Embolization Particle Market by Type Revenue (Billion), by Structure 2026 & 2034
Figure 5: North America Embolization Particle Market by Type Revenue Share (%), by Structure 2026 & 2034
Figure 6: North America Embolization Particle Market by Type Revenue (Billion), by Function 2026 & 2034
Figure 7: North America Embolization Particle Market by Type Revenue Share (%), by Function 2026 & 2034
Figure 8: North America Embolization Particle Market by Type Revenue (Billion), by Material 2026 & 2034
Figure 9: North America Embolization Particle Market by Type Revenue Share (%), by Material 2026 & 2034
Figure 10: North America Embolization Particle Market by Type Revenue (Billion), by Particle Size 2026 & 2034
Figure 11: North America Embolization Particle Market by Type Revenue Share (%), by Particle Size 2026 & 2034
Figure 12: North America Embolization Particle Market by Type Revenue (Billion), by Delivery Format 2026 & 2034
Figure 13: North America Embolization Particle Market by Type Revenue Share (%), by Delivery Format 2026 & 2034
Figure 14: North America Embolization Particle Market by Type Revenue (Billion), by Application 2026 & 2034
Figure 15: North America Embolization Particle Market by Type Revenue Share (%), by Application 2026 & 2034
List of Tables
Table 1: Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 2: Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 3: Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 4: Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 5: Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 6: Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Table 7: Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 8: Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 9: Embolization Particle Market by Type Revenue Billion Forecast, by Region 2020 & 2034
Table 10: North America Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 11: North America Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 12: North America Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 13: North America Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 14: North America Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 15: North America Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Frequently Asked Questions
1. What is the largest embolization particle type by revenue?
Radioembolization particles held the largest type share of the market in 2025, driven by yttrium-90 glass and resin microspheres used in liver cancer treatment. Drug-eluting beads are the fastest-growing type, supported by the market's 12.27% CAGR through 2034.
2. Which embolization particle type is growing fastest?
Drug-eluting beads are projected to grow at the highest CAGR, as chemoembolization shifts toward sustained local drug release. Calibrated spherical microspheres also outpace irregular particles due to predictable occlusion and lower catheter clogging.
3. Which material leads the embolization particle market by type?
PVA-based materials hold the largest material share in 2025, followed by tris-acryl gelatin microspheres. Ceramic and bioresorbable microspheres represent the emerging material frontier with joint-development activity in late 2024.
4. Which particle size band dominates demand?
The 100-300 µm band leads particle size segmentation, balancing deep tumor penetration against safe occlusion of feeding vessels. Narrower precision bands are gaining traction for patient-specific dosimetry planning.
5. How large is the embolization particle market?
The global market was valued at approximately USD 1.34 billion in 2025 and is forecast to reach USD 3.79 billion by 2034, expanding at a 12.27% CAGR. Oncology and peripheral vascular disease applications anchor demand.
Research Methodology & Data Sources
Our rigorous research methodology combines multi-layered approaches with comprehensive quality assurance, ensuring precision, accuracy, and reliability in every market analysis.
Primary Research
70–80% of all inputs originate from primary research, including structured interviews with interventional radiologists, embolization product managers, and hospital procurement leads.
Verified participant mix spans particle and microsphere manufacturers, contract sterilization providers, catheter and microcatheter OEMs, hospital IR departments, and specialty distributors.
Interviews are conducted across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa to capture type-level and application-level demand differences.
Key Stakeholders Interviewed
Key Stakeholders Interviewed
Stakeholder Role
Interview Share (%)
Procurement Director
28%
Interventional Radiologist
34%
Regulatory Affairs Manager
19%
Product & Portfolio Manager
19%
Industry Ecosystem Breakdown
Industry Ecosystem Breakdown
Company Type
Representation (%)
Embolization Particle & Microsphere Manufacturers
32%
Microcatheter & Delivery System OEMs
21%
Contract Sterilization & Packaging Providers
13%
Hospitals & Interventional Radiology Centers
24%
Specialty Medical Distributors
10%
Secondary Research & Industry Benchmarking
20–30% of inputs derive from secondary research using Bloomberg, Factiva, Hoovers, and PitchBook for corporate financials, deal activity, and portfolio mapping.
Technical standards and clinical guidance from recognized non-profit bodies (e.g., cardiovascular and interventional radiology societies) calibrate procedure-volume assumptions.
Demand Modeling & Market Estimation
Bottom-up build quantifies particle consumption using procedure volumes, average particles consumed per embolization procedure, and average selling price per vial by type.
Type-level metrics include vials consumed per radioembolization case, drug-eluting bead kit utilization per chemoembolization session, and particle size band mix per indication.
Top-down methodology applies interventional radiology spend envelopes and embolization device market splits, validated through multi-level data triangulation against bottom-up outputs.
Every report is updated to the date of purchase, with model refresh cycles aligned to new regulatory clearances and product launches.
Data Accuracy & Quality Check
Estimated data accuracy is guaranteed at 85–90%, with confidence bands reported on every forecast table.
Cross-validation triangulates interview responses, trade statistics, and company disclosures before any figure is published.
Outlier screening removes double counting in distributor-level reporting and reconciles currency and sterilization-cost normalization across regions.
11.1.9.2. Products
11.1.9.3. Company Financials
11.1.9.4. SWOT Analysis
11.1.10. Kavya Pharma
11.1.10.1. Company Overview
11.1.10.2. Products
11.1.10.3. Company Financials
11.1.10.4. SWOT Analysis
11.1.11. AngioDynamics
11.1.11.1. Company Overview
11.1.11.2. Products
11.1.11.3. Company Financials
11.1.11.4. SWOT Analysis
11.1.12. Stryker Corporation
11.1.12.1. Company Overview
11.1.12.2. Products
11.1.12.3. Company Financials
11.1.12.4. SWOT Analysis
11.1.13. B. Braun Melsungen AG
11.1.13.1. Company Overview
11.1.13.2. Products
11.1.13.3. Company Financials
11.1.13.4. SWOT Analysis
11.1.14. Asahi Intecc
11.1.14.1. Company Overview
11.1.14.2. Products
11.1.14.3. Company Financials
11.1.14.4. SWOT Analysis
11.1.15. Penumbra Inc.
11.1.15.1. Company Overview
11.1.15.2. Products
11.1.15.3. Company Financials
11.1.15.4. SWOT Analysis
11.2. Market Entropy
11.2.1. Company's Key Areas Served
11.2.2. Recent Developments
11.3. Company Market Share Analysis, 2026
11.3.1. Top 5 Companies Market Share Analysis
11.3.2. Top 3 Companies Market Share Analysis
11.4. List of Potential Customers
Figure 16: North America Embolization Particle Market by Type Revenue (Billion), by End Use 2026 & 2034
Figure 17: North America Embolization Particle Market by Type Revenue Share (%), by End Use 2026 & 2034
Figure 18: North America Embolization Particle Market by Type Revenue (Billion), by Country 2026 & 2034
Figure 19: North America Embolization Particle Market by Type Revenue Share (%), by Country 2026 & 2034
Figure 20: Europe Embolization Particle Market by Type Revenue (Billion), by Product Type 2026 & 2034
Figure 21: Europe Embolization Particle Market by Type Revenue Share (%), by Product Type 2026 & 2034
Figure 22: Europe Embolization Particle Market by Type Revenue (Billion), by Structure 2026 & 2034
Figure 23: Europe Embolization Particle Market by Type Revenue Share (%), by Structure 2026 & 2034
Figure 24: Europe Embolization Particle Market by Type Revenue (Billion), by Function 2026 & 2034
Figure 25: Europe Embolization Particle Market by Type Revenue Share (%), by Function 2026 & 2034
Figure 26: Europe Embolization Particle Market by Type Revenue (Billion), by Material 2026 & 2034
Figure 27: Europe Embolization Particle Market by Type Revenue Share (%), by Material 2026 & 2034
Figure 28: Europe Embolization Particle Market by Type Revenue (Billion), by Particle Size 2026 & 2034
Figure 29: Europe Embolization Particle Market by Type Revenue Share (%), by Particle Size 2026 & 2034
Figure 30: Europe Embolization Particle Market by Type Revenue (Billion), by Delivery Format 2026 & 2034
Figure 31: Europe Embolization Particle Market by Type Revenue Share (%), by Delivery Format 2026 & 2034
Figure 32: Europe Embolization Particle Market by Type Revenue (Billion), by Application 2026 & 2034
Figure 33: Europe Embolization Particle Market by Type Revenue Share (%), by Application 2026 & 2034
Figure 34: Europe Embolization Particle Market by Type Revenue (Billion), by End Use 2026 & 2034
Figure 35: Europe Embolization Particle Market by Type Revenue Share (%), by End Use 2026 & 2034
Figure 36: Europe Embolization Particle Market by Type Revenue (Billion), by Country 2026 & 2034
Figure 37: Europe Embolization Particle Market by Type Revenue Share (%), by Country 2026 & 2034
Figure 38: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Product Type 2026 & 2034
Figure 39: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Product Type 2026 & 2034
Figure 40: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Structure 2026 & 2034
Figure 41: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Structure 2026 & 2034
Figure 42: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Function 2026 & 2034
Figure 43: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Function 2026 & 2034
Figure 44: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Material 2026 & 2034
Figure 45: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Material 2026 & 2034
Figure 46: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Particle Size 2026 & 2034
Figure 47: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Particle Size 2026 & 2034
Figure 48: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Delivery Format 2026 & 2034
Figure 49: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Delivery Format 2026 & 2034
Figure 50: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Application 2026 & 2034
Figure 51: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Application 2026 & 2034
Figure 52: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by End Use 2026 & 2034
Figure 53: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by End Use 2026 & 2034
Figure 54: Asia Pacific Embolization Particle Market by Type Revenue (Billion), by Country 2026 & 2034
Figure 55: Asia Pacific Embolization Particle Market by Type Revenue Share (%), by Country 2026 & 2034
Figure 56: Latin America Embolization Particle Market by Type Revenue (Billion), by Product Type 2026 & 2034
Figure 57: Latin America Embolization Particle Market by Type Revenue Share (%), by Product Type 2026 & 2034
Figure 58: Latin America Embolization Particle Market by Type Revenue (Billion), by Structure 2026 & 2034
Figure 59: Latin America Embolization Particle Market by Type Revenue Share (%), by Structure 2026 & 2034
Figure 60: Latin America Embolization Particle Market by Type Revenue (Billion), by Function 2026 & 2034
Figure 61: Latin America Embolization Particle Market by Type Revenue Share (%), by Function 2026 & 2034
Figure 62: Latin America Embolization Particle Market by Type Revenue (Billion), by Material 2026 & 2034
Figure 63: Latin America Embolization Particle Market by Type Revenue Share (%), by Material 2026 & 2034
Figure 64: Latin America Embolization Particle Market by Type Revenue (Billion), by Particle Size 2026 & 2034
Figure 65: Latin America Embolization Particle Market by Type Revenue Share (%), by Particle Size 2026 & 2034
Figure 66: Latin America Embolization Particle Market by Type Revenue (Billion), by Delivery Format 2026 & 2034
Figure 67: Latin America Embolization Particle Market by Type Revenue Share (%), by Delivery Format 2026 & 2034
Figure 68: Latin America Embolization Particle Market by Type Revenue (Billion), by Application 2026 & 2034
Figure 69: Latin America Embolization Particle Market by Type Revenue Share (%), by Application 2026 & 2034
Figure 70: Latin America Embolization Particle Market by Type Revenue (Billion), by End Use 2026 & 2034
Figure 71: Latin America Embolization Particle Market by Type Revenue Share (%), by End Use 2026 & 2034
Figure 72: Latin America Embolization Particle Market by Type Revenue (Billion), by Country 2026 & 2034
Figure 73: Latin America Embolization Particle Market by Type Revenue Share (%), by Country 2026 & 2034
Figure 74: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Product Type 2026 & 2034
Figure 75: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Product Type 2026 & 2034
Figure 76: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Structure 2026 & 2034
Figure 77: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Structure 2026 & 2034
Figure 78: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Function 2026 & 2034
Figure 79: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Function 2026 & 2034
Figure 80: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Material 2026 & 2034
Figure 81: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Material 2026 & 2034
Figure 82: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Particle Size 2026 & 2034
Figure 83: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Particle Size 2026 & 2034
Figure 84: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Delivery Format 2026 & 2034
Figure 85: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Delivery Format 2026 & 2034
Figure 86: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Application 2026 & 2034
Figure 87: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Application 2026 & 2034
Figure 88: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by End Use 2026 & 2034
Figure 89: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by End Use 2026 & 2034
Figure 90: Middle East & Africa Embolization Particle Market by Type Revenue (Billion), by Country 2026 & 2034
Figure 91: Middle East & Africa Embolization Particle Market by Type Revenue Share (%), by Country 2026 & 2034
Table 16: North America Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 17: North America Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 18: North America Embolization Particle Market by Type Revenue Billion Forecast, by Country 2020 & 2034
Table 19: USA Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 20: Canada Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 21: Mexico Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 22: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 23: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 24: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 25: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 26: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 27: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Table 28: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 29: Europe Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 30: Europe Embolization Particle Market by Type Revenue Billion Forecast, by Country 2020 & 2034
Table 31: Germany Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 32: UK Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 33: France Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 34: Italy Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 35: Spain Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 36: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 37: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 38: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 39: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 40: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 41: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Table 42: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 43: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 44: Asia Pacific Embolization Particle Market by Type Revenue Billion Forecast, by Country 2020 & 2034
Table 45: China Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 46: Japan Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 47: India Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 48: South Korea Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 49: Australia Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 50: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 51: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 52: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 53: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 54: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 55: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Table 56: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 57: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 58: Latin America Embolization Particle Market by Type Revenue Billion Forecast, by Country 2020 & 2034
Table 59: Brazil Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 60: Argentina Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 61: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Product Type 2020 & 2034
Table 62: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Structure 2020 & 2034
Table 63: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Function 2020 & 2034
Table 64: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Material 2020 & 2034
Table 65: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Particle Size 2020 & 2034
Table 66: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Delivery Format 2020 & 2034
Table 67: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Application 2020 & 2034
Table 68: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by End Use 2020 & 2034
Table 69: Middle East & Africa Embolization Particle Market by Type Revenue Billion Forecast, by Country 2020 & 2034
Table 70: UAE Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 71: Saudi Arabia Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Table 72: South Africa Embolization Particle Market by Type Revenue (Billion) Forecast, by Application 2020 & 2034
Embolization Particle Market by Type.jpg){kind=small}
